Literature DB >> 28456118

DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.

Laila H Abdel-Rahman1, Ahmed M Abu-Dief2, Moustafa O Aboelez3, Azza A Hassan Abdel-Mawgoud1.   

Abstract

The present study was conducted to synthesis of some new imine Cr(III), VO(II), Mn(II) and Ni(II) complexes derived from the condensation of 2-amino phenol with 2-hydroxynapthaldehyde were synthesized. The prepared HNPN imine ligand was analyzed by its melting point, IR, 1H NMR and 13C NMR spectroscopies. The investigated HNPN imine complexes were characterized by elemental analysis, FT IR, UV-vis and thermal analysis (TGA) under nitrogen atmosphere from ambient temperature to 750°C. The experimental results revealed that the investigated complexes contain hydrated water molecules. The molar conductance values of complexes are relatively low, indicating the non-electrolytic nature of these complexes. Magnetic susceptibility measurements show that the investigated complexes are paramagnetic. Moreover, the stability constants of the preparing complexes were determined spectrophotometrically. All the complexes were found to be monomeric 1:1 (M:L) stoichiometry in nature with octahedral geometry for Cr(III), tetrahedral for Mn(II), square planner for Ni(II) and square pyramidal for VO(II). Moreover, the prepared HNPN imine ligand and its complexes were evaluated for antimicrobial effect against some types of bacteria such as Bacillus subtilis (+ve), Escherichia coli(-ve) and Staphylococcus aureus (+ve) and some types of fungi such as Aspergillusniger, Candida glabrata and Trichophyton rubrum. The results of these studies indicate that the metal complexes exhibit a stronger antibacterial and antifungal efficiency compared to their corresponding imine ligand. Moreover, the interaction of the investigated complexes with CT-DNA was checked using spectral studies, viscosity measurements and gel electrophoreses. The absorption titration studies revealed that each of these complexes is an avid binder to calf thymus-DNA. Also, there was appreciable changes in the relative viscosity of DNA, which is consistent with enhanced hydrophobic interaction of the aromatic rings and intercalation mode of binding. In addition to, the cytotoxic activity of the prepared imine complexes on human colon carcinoma cells, (HCT-116 cell line), hepatic cellular carcinoma cells, (HepG-2 cell line) and breast carcinoma cells (MCF-7 cell line) has cytotoxicity effect against growth of carcinoma cells compared to the clinically used Vinblastine standard. Furthermore, the molecular docking into TRK (PDB: 1t46) was done for the optimization of the investigated compounds as potential TRK inhibitors.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Anticancer; Antimicrobial activity; Chelates; DNA interaction; Imines; Molecular docking analysis; Thermal analyses

Mesh:

Substances:

Year:  2017        PMID: 28456118     DOI: 10.1016/j.jphotobiol.2017.04.003

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking.

Authors:  Ana-Maria Udrea; Speranta Avram; Simona Nistorescu; Mihail-Lucian Pascu; Mihaela Oana Romanitan
Journal:  J Photochem Photobiol B       Date:  2020-08-15       Impact factor: 6.252

Review 2.  Schiff bases and their metal complexes as urease inhibitors - A brief review.

Authors:  Ângelo de Fátima; Camila de Paula Pereira; Carolina Raquel Said Dau Gonçalves Olímpio; Breno Germano de Freitas Oliveira; Lucas Lopardi Franco; Pedro Henrique Corrêa da Silva
Journal:  J Adv Res       Date:  2018-03-26       Impact factor: 10.479

3.  Fabrication, DFT Calculation, and Molecular Docking of Two Fe(III) Imine Chelates as Anti-COVID-19 and Pharmaceutical Drug Candidate.

Authors:  Hany M Abd El-Lateef; Mai M Khalaf; Mohamed R Shehata; Ahmed M Abu-Dief
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

4.  Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Bakheet E M Elsadek; Hatem A Sarhan; Khaled Ali Khaled; Amany Belal; Ahmed Khames; Yasser A Hassan; Amany A Abdel-Rheem; Eslam B Elkaeed; Mohamed Raafat; Mahmoud Elkot Mostafa Elsadek
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

5.  Biological and catalytic potential of sustainable low and high valent metal-Schiff base sulfonate salicylidene pincer complexes.

Authors:  Mohamed Shaker S Adam; Omar M El-Hady; Farman Ullah
Journal:  RSC Adv       Date:  2019-10-25       Impact factor: 4.036

6.  Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Mohamed S Mohamed; Reda A Mahmoud; Ahmed A El-Shenawy; Essam A Mahmoud; Ahmed A Al-Karmalawy; Eman Y Santali; Sameer Alshehri; Mahmoud Elkot Mostafa Elsadek; Mohamed A El Hamd; Abd El Hakim Ramadan
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

7.  Synthesis, Spectroscopic, and Biological Studies of Mixed Ligand Complexes of Gemifloxacin and Glycine with Zn(II), Sn(II), and Ce(III).

Authors:  Shimaa H Sakr; Hazem S Elshafie; Ippolito Camele; Sadeek A Sadeek
Journal:  Molecules       Date:  2018-05-15       Impact factor: 4.411

8.  Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2).

Authors:  Mohammad Nasir Uddin; Md Shaharier Amin; Md Saifur Rahman; Sonia Khandaker; Wahhida Shumi; Md Atiar Rahman; Sheikh Mahbubur Rahman
Journal:  Appl Organomet Chem       Date:  2020-10-19       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.